Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon Apr 16, 2020 9:54am

155 Views

Post# 30915801

RE:CC

Medicure takes a 4 month break from any news & finally releases this disaster. $3m in q4 revs from aggrastat, they burned through nearly $60m in a year's time & then they decide to cut costs & become profitable? Their $10m investment in Sensible is now worth $4m? And how about those promised agg. trial results news in dec. promised in q1 2020. Direction in this co. is sorely lacking.

Bullboard Posts

2024, a breakthrough year for silver